iPLA2γ Polyclonal Antibody

货号：ES2637
价格：面议
点击：2450

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Mouse
别称	PNPLA8; IPLA22; IPLA2G; BM-043; Calcium-independent phospholipase A2-gamma; Intracellular membrane-associated calcium-independent phospholipase A2 gamma; iPLA2-gamma; PNPLA-gamma; Patatin-like phospholipase domain-containing protein 8; iPLA

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	360
Anti-Isatuximab Non-Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗非中和重组抗体(靶标：艾沙妥昔单抗非中和抗体)	586
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	469
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	320
Anti-Isatuximab Neutralizing Recombinant Antibody \|抗艾沙妥昔单抗中和重组抗体(靶标：艾沙妥昔单抗中和抗体)	280
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	549
Anti-Urelumab Non-Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗非中和重组抗体(靶标：乌瑞鲁单抗非中和抗体)	564
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	600
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	573
Anti-Urelumab Neutralizing Recombinant Antibody \|抗乌瑞鲁单抗中和重组抗体(靶标：乌瑞鲁单抗中和抗体)	518
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	312
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	421
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	626
Anti-Risankizumab Neutralizing Recombinant Antibody \|抗瑞莎珠单抗中和重组抗体(靶标：瑞莎珠单抗中和抗体)	307
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	508
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	400
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody \|抗雷珠单抗非中和重组抗体(靶标：雷珠单抗非中和抗体)	503
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	372
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	503
Anti-Ranibizumab Neutralizing Recombinant Antibody \|抗雷珠单抗中和重组抗体(靶标：雷珠单抗中和抗体)	295